ubmslatePT-logo-ubm

PT Mobile Logo

Search form

Topics:

Psychiatric Times

What's on the Horizon?

A new drug in development for negative symptoms of schizophrenia. ©NataLunata/Shutterstock


 

Recent Content

King is singularly adept at capturing the vicissitudes, mores, and speech of pre-teenagers (particularly boys) throughout his writing—most notably in one of his longest novels, IT.

The sequel probes the big questions without flinging them in the viewer’s face. How does memory articulate with one’s sense of origin and purpose—and, above all, of death?

What does the evidence tell us about digital sensors for treatment adherence in patients with schizophrenia and other psychiatric disorders?

© SHUTTERSTOCK.COM

Here's a warm welcome to the 7 members of our new Advisory Board.

Please! No more group hugs!

Know about these two articles of major importance for those interested in strengthening the evidence base for psychotherapy?

The author explores the significant pharmacokinetic and pharmacodynamic heterogeneity of current antidepressants and reviews the many potential drug targets that exist—with a focus on the serotonin system.

CME Center

Earn CME Credits for reading Psychiatric Times articles. Click here to go to our free online CME activities.

By clicking Accept, you agree to become a member of the UBM Medica Community.